CARDINAL HEALTH INC (CAH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Annual

0 90B 180B 270B FY08: 87.4B FY09: 96B FY10: 98.5B FY11: 102.6B FY12: 107.6B FY13: 101.1B FY14: 91.1B FY15: 102.5B FY16: 121.5B FY17: 130B FY18: 136.8B FY19: 145.5B FY20: 152.9B FY21: 162.5B FY22: 181.3B FY23: 205B FY24: 226.8B FY25: 222.6B FY26: 254.2B FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Gross Profit Annual

0 3.5B 7B 10.5B FY08: 3.8B FY09: 3.7B FY10: 3.8B FY11: 4.2B FY12: 4.5B FY13: 4.9B FY14: 5.2B FY15: 5.7B FY16: 6.5B FY17: 6.5B FY18: 7.2B FY19: 6.8B FY20: 6.9B FY21: 6.8B FY22: 6.5B FY23: 6.9B FY24: 7.4B FY25: 8.2B FY26: 9.8B FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating Income Annual

-4.5B -3B -1.5B 0 1.5B 3B 4.5B FY08: 1.4B FY09: 1.3B FY10: 1.3B FY11: 1.5B FY12: 1.8B FY13: 996M FY14: 1.9B FY15: 2.2B FY16: 2.5B FY17: 2.1B FY18: 126M FY19: 2.1B FY20: -4.1B FY21: 472M FY22: -607M FY23: 752M FY24: 1.2B FY25: 2.3B FY26: 2.6B FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Net Income Annual

-4.5B -3B -1.5B 0 1.5B 3B 4.5B FY08: 1.3B FY09: 1.2B FY10: 642M FY11: 959M FY12: 1.1B FY13: 334M FY14: 1.2B FY15: 1.2B FY16: 1.4B FY17: 1.3B FY18: 256M FY19: 1.4B FY20: -3.7B FY21: 611M FY22: -938M FY23: 330M FY24: 852M FY25: 1.6B FY26: 1.7B FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Cost of Revenue Annual

0 90B 180B 270B FY16: 115B FY17: 123.4B FY18: 129.6B FY19: 138.7B FY20: 146.1B FY21: 155.7B FY22: 174.8B FY23: 198.1B FY24: 219.4B FY25: 214.4B FY26: 244.5B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

0 2B 4B 6B FY08: 1.5B FY09: 1.4B FY10: 2.1B FY11: 1.4B FY12: 1.2B FY13: 1.7B FY14: 2.5B FY15: 2.5B FY16: 3B FY17: 1.2B FY18: 2.8B FY19: 2.7B FY20: 2B FY21: 2.4B FY22: 3.2B FY23: 2.8B FY24: 3.8B FY25: 2.4B FY26: 5.2B FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Free Cash Flow Annual

0 2B 4B 6B FY09: 1B FY10: 1.9B FY11: 1.1B FY12: 916M FY13: 1.5B FY14: 2.3B FY15: 2.2B FY16: 2.5B FY17: 797M FY18: 2.4B FY19: 2.4B FY20: 1.6B FY21: 2B FY22: 2.8B FY23: 2.4B FY24: 3.3B FY25: 1.9B FY26: 4.5B FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 150M 300M 450M FY08: 364M FY09: 361.5M FY10: 361M FY11: 353M FY12: 349M FY13: 344M FY14: 345M FY15: 335M FY16: 330M FY17: 320M FY18: 315M FY19: 301M FY20: 293M FY21: 294M FY22: 279M FY23: 262M FY24: 247M FY25: 242M FY26: 237M FY08 FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q4 '09: 3.00 Q1 '10: 2.20 Q2 '10: 1.97 Q3 '10: 1.71 Q4 '10: 1.69 Q1 '11: 2.64 Q2 '11: 2.60 Q3 '11: 2.69 Q4 '11: 2.73 Q1 '12: 2.57 Q2 '12: 2.71 Q3 '12: 2.96 Q4 '12: 3.06 Q1 '13: 3.17 Q2 '13: 3.30 Q3 '13: 3.35 Q4 '14: 3.38 Q1 '15: 3.17 Q2 '15: 3.23 Q3 '15: 3.41 Q4 '15: 3.61 Q1 '16: 3.98 Q2 '16: 4.10 Q3 '16: 4.18 Q4 '16: 4.32 Q4 '23: 1.26 Q1 '24: 0.81 Q2 '24: 2.61 Q3 '24: 2.27 Q4 '24: 3.45 Q1 '25: 5.20 Q2 '10 Q2 '11 Q2 '12 Q2 '13 Q2 '15 Q2 '16 Q1 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.